NCT00289185 - Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants | Biotech Hunter

Enrollment

340

Participants

Timeline

Start Date

September 27, 2006

Primary Completion Date

February 11, 2008

Study Completion Date

January 15, 2009

Conditions

MalariaMalaria Vaccines

Interventions

BIOLOGICAL

RTS,S/AS02D

3-dose intramuscular injection in the thigh

BIOLOGICAL

Engerix-B®

3-dose intramuscular injection in the thigh.

BIOLOGICAL

TETRActHib™

3-dose intramuscular injection in the thigh.

Trial Locations (1)

GSK Investigational Site, Dar es Salaam